Chronic kidney disease as a cardiovascular risk factor

Area of Science:

• Nephrology
• Cardiology
• Public Health

Background:

• Chronic kidney disease (CKD) significantly increases cardiovascular disease (CVD) risk and mortality.
• CKD is recognized as a marker for high or very high cardiovascular risk, necessitating prompt management.
• Cardiovascular risk factors, including hypertension, dyslipidemia, and diabetes, are prevalent and critical in CKD patients.

Purpose of the Study:

• To outline essential strategies for managing cardiovascular risk in patients with chronic kidney disease.
• To emphasize the importance of lifestyle modifications and pharmacological interventions for combined cardiovascular and kidney protection.
• To provide updated recommendations for blood pressure, diabetes, and dyslipidemia management in CKD.

Main Methods:

• Review of current guidelines and evidence for managing cardiovascular risk factors in CKD.
• Analysis of recommended lifestyle interventions: smoking cessation, weight reduction, physical activity, and dietary changes.
• Evaluation of pharmacological strategies for hypertension, diabetes (including iSGLT2 and GLP-1RA), and dyslipidemia (statins, ezetimibe, PCSK9 inhibitors).

Main Results:

• Lowering office blood pressure (BP) to 130/80 mmHg or lower is recommended, with out-of-office monitoring advised.
• Diabetes management includes lifestyle changes and metformin for prediabetes, with iSGLT2 and GLP-1RA for type 2 diabetes (T2D) at high cardiovascular risk.
• Specific LDL-C goals and statin therapies are recommended based on CKD stage, with consideration for PCSK9 inhibitors in advanced stages.

Conclusions:

• Integrated management of cardiovascular risk factors is paramount for patients with CKD.
• Lifestyle modifications and tailored pharmacological treatments are essential for improving outcomes.
• Adherence to recommended treatment goals for BP, diabetes, and dyslipidemia can mitigate cardiovascular and renal complications.